Why the tolerance of potential harms? Research ethics in Alzheimer disease.
D016223:Advance Directives; D026683:Advisory Committees; D032802:Committee Membership; D003704:Dementia; D034462:Dissent and Disputes; D004989:Ethics; D017041:Ethics Committees; D028744:Ethics Committees, Research; D032984:Ethics, Research; D006040:Goals; D006126:Group Processes; D017408:Guidelines as Topic; D006805:Human Experimentation; D006801:Humans; D007258:Informed Consent; D016743:Mental Competency; D033281:Nontherapeutic Human Experimentation; D009934:Organization and Administration; D016134:Organizational Policy; D010344:Patient Advocacy; D004364:Pharmaceutical Preparations; D011057:Politics; D011315:Preventive Medicine; D011640:Public Policy; D012106:Research; D035842:Research Subjects; D012306:Risk; D036302:Therapeutic Human Experimentation; D020458:Third-Party Consent; D014481:United States
Alzheimer's Disease and Related Disorders Association; Biomedical and Behavioral Research; Mental Health Therapies; National Bioethics Advisory Commission